阿片类药物处方连续性与危险阿片类药物处方
Opioid-Prescribing Continuity and Risky Opioid Prescriptions.
机构信息
HealthInsight Oregon, Portland, Oregon
Portland State University, Portland, Oregon.
出版信息
Ann Fam Med. 2018 Sep;16(5):440-442. doi: 10.1370/afm.2285.
Abstract
We aimed to better understand the association between opioid-prescribing continuity, risky prescribing patterns, and overdose risk. For this retrospective cohort study, we included patients with long-term opioid use, pulling data from Oregon's Prescription Drug Monitoring Program (PDMP), vital records, and hospital discharge registry. A continuity of care index (COCI) score was calculated for each patient, and we defined metrics to describe risky prescribing and overdose. As prescribing continuity increased, likelihood of filling risky opioid prescriptions and overdose hospitalization decreased. Prescribing continuity is an important factor associated with opioid harms and can be calculated using administrative pharmacy data.
摘要
我们旨在更好地理解阿片类药物处方连续性、高风险处方模式与药物过量风险之间的关联。在这项回顾性队列研究中，我们纳入了长期使用阿片类药物的患者，从俄勒冈州的处方药物监测计划（PDMP）、生命记录和医院出院登记处提取数据。为每位患者计算了一个连续性护理指数（COCI）评分，我们还定义了描述高风险处方和药物过量的指标。随着处方连续性的增加，开出高风险阿片类药物处方和药物过量住院的可能性降低。处方连续性是与阿片类药物危害相关的一个重要因素，可使用行政药房数据计算得出。
相似文献
1
Opioid-Prescribing Continuity and Risky Opioid Prescriptions.阿片类药物处方连续性与危险阿片类药物处方
Ann Fam Med. 2018 Sep;16(5):440-442. doi: 10.1370/afm.2285.
2
Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.处方药物监测计划的使用与阿片类药物处方和健康结果的关联：使用者与非使用者的比较。
J Pain. 2018 Feb;19(2):166-177. doi: 10.1016/j.jpain.2017.10.001. Epub 2017 Oct 18.
3
The effects of state rules on opioid prescribing in Indiana.印第安纳州的州法规对阿片类药物处方的影响。
BMC Health Serv Res. 2018 Jan 18;18(1):29. doi: 10.1186/s12913-018-2830-6.
4
Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.在俄勒冈州处方药物监测计划中，按医师类型划分的阿片类药物处方模式和患者结局。
Pain Med. 2018 Dec 1;19(12):2481-2486. doi: 10.1093/pm/pnx283.
5
Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.处方药监测项目与医生持续减少阿片类药物处方量有关。
Health Aff (Millwood). 2016 Jun 1;35(6):1045-51. doi: 10.1377/hlthaff.2015.1673.
6
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.受控物质处方模式 - 处方行为监测系统，八个州，2013 年。
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
7
Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.阿片类药物处方行为-处方行为监测系统，11 个州，2010-2016 年。
MMWR Surveill Summ. 2020 Jan 31;69(1):1-14. doi: 10.15585/mmwr.ss6901a1.
8
Potentially Inappropriate Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011-2015.2011-2015 年马萨诸塞州潜在不适当阿片类药物处方、用药过量和死亡率。
J Gen Intern Med. 2018 Sep;33(9):1512-1519. doi: 10.1007/s11606-018-4532-5. Epub 2018 Jun 14.
9
Opioid prescribing is rising in many countries.许多国家的阿片类药物处方量正在上升。
BMJ. 2019 Oct 17;367:l5823. doi: 10.1136/bmj.l5823.
10
Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.生命体征：2006 - 2015年美国阿片类药物处方的变化
MMWR Morb Mortal Wkly Rep. 2017 Jul 7;66(26):697-704. doi: 10.15585/mmwr.mm6626a4.
引用本文的文献
1
Opioid Tapering and Opioid Overdose, Opioid Use Disorder, and Mortality Among Older Adults: A Nested Case-Control Study.阿片类药物减量与老年人阿片类药物过量、阿片类药物使用障碍及死亡率：一项巢式病例对照研究
J Gen Intern Med. 2025 Apr 22. doi: 10.1007/s11606-025-09492-9.
2
Personal Continuity and Appropriate Prescribing in Primary Care.初级保健中的个人连续性和适当处方
Ann Fam Med. 2023 Jul-Aug;21(4):305-312. doi: 10.1370/afm.2994.
3
Continuity of opioid prescribing among older adults on long-term opioids.长期使用阿片类药物的老年人的阿片类药物处方连续性。
Am J Manag Care. 2023 Feb;29(2):88-94. doi: 10.37765/ajmc.2023.89317.
4
Characterizations of Opioid Prescribing in Community Health Centers in 2018.2018 年社区卫生中心的阿片类药物处方特征。
J Prim Care Community Health. 2022 Jan-Dec;13:21501319221074115. doi: 10.1177/21501319221074115.
5
Concurrent Use of Prescription Opioids and Gabapentinoids in Older Adults.老年人同时使用处方阿片类药物和加巴喷丁类药物。
Am J Prev Med. 2022 Apr;62(4):519-528. doi: 10.1016/j.amepre.2021.08.024. Epub 2021 Nov 19.
6
Assessing opioid overdose risk: a review of clinical prediction models utilizing patient-level data.评估阿片类药物过量风险：利用患者水平数据的临床预测模型综述。
Transl Res. 2021 Aug;234:74-87. doi: 10.1016/j.trsl.2021.03.012. Epub 2021 Mar 21.
7
Advances in prescription drug monitoring program research: a literature synthesis (June 2018 to December 2019).处方药物监测计划研究进展：文献综述（2018 年 6 月至 2019 年 12 月）。
Curr Opin Psychiatry. 2020 Jul;33(4):326-333. doi: 10.1097/YCO.0000000000000608.
8
Predicting Opioid Use Following Discharge After Cesarean Delivery.预测剖宫产术后出院后阿片类药物的使用情况。
Ann Fam Med. 2020 Mar;18(2):118-126. doi: 10.1370/afm.2493.
9
Record Linkage Approaches Using Prescription Drug Monitoring Program and Mortality Data for Public Health Analyses and Epidemiologic Studies.利用处方药物监测计划和死亡率数据进行公共卫生分析和流行病学研究的记录链接方法。
Epidemiology. 2020 Jan;31(1):22-31. doi: 10.1097/EDE.0000000000001110.
10
Association between cannabis laws and opioid prescriptions among privately insured adults in the US.美国私人保险成年人中，大麻法律与阿片类药物处方之间的关联。
Prev Med. 2019 Aug;125:62-68. doi: 10.1016/j.ypmed.2019.05.012. Epub 2019 May 21.
本文引用的文献
1
Association Between Initial Opioid Prescribing Patterns and Subsequent Long-Term Use Among Opioid-Naïve Patients: A Statewide Retrospective Cohort Study.初治阿片类药物患者初始阿片类药物处方模式与后续长期使用之间的关联：一项全州范围的回顾性队列研究。
J Gen Intern Med. 2017 Jan;32(1):21-27. doi: 10.1007/s11606-016-3810-3. Epub 2016 Aug 2.
2
Preparing a prescription drug monitoring program data set for research purposes.为研究目的准备处方药监测项目数据集。
Pharmacoepidemiol Drug Saf. 2016 Sep;25(9):993-7. doi: 10.1002/pds.4039. Epub 2016 Jun 6.
3
CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.美国 2016 年慢性疼痛阿片类药物处方指南。
JAMA. 2016 Apr 19;315(15):1624-45. doi: 10.1001/jama.2016.1464.
4
Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.药物和阿片类药物过量死亡人数增加 - 美国，2000-2014 年。
MMWR Morb Mortal Wkly Rep. 2016 Jan 1;64(50-51):1378-82. doi: 10.15585/mmwr.mm6450a3.
5
Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis.慢性疼痛中阿片类药物滥用、误用及成瘾率：一项系统评价与数据综合分析
Pain. 2015 Apr;156(4):569-576. doi: 10.1097/01.j.pain.0000460357.01998.f1.
6
The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.长期阿片类药物治疗慢性疼痛的效果和风险：美国国立卫生研究院预防途径研讨会的系统评价。
Ann Intern Med. 2015 Feb 17;162(4):276-86. doi: 10.7326/M14-2559.
7
Measuring Care Continuity: A Comparison of Claims-based Methods.衡量护理连续性：基于索赔方法的比较。
Med Care. 2016 May;54(5):e30-4. doi: 10.1097/MLR.0000000000000018.
8
Effect of a centralized prescription network on inappropriate prescriptions for opioid analgesics and benzodiazepines.集中处方网络对阿片类镇痛药和苯二氮䓬类药物不合理处方的影响。
CMAJ. 2012 Nov 6;184(16):E852-6. doi: 10.1503/cmaj.120465. Epub 2012 Sep 4.
9
Opioids for back pain patients: primary care prescribing patterns and use of services.慢性疼痛患者使用阿片类药物：初级保健的处方模式和服务利用情况。
J Am Board Fam Med. 2011 Nov-Dec;24(6):717-27. doi: 10.3122/jabfm.2011.06.100232.
Zotero 插件